Concepedia

Rachel Okabe

RO

19

Publications

2.8K

Citations

17

H-Index

2004

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Howard Hughes Medical Institute

Merck & Co., Inc., Rahway, NJ, USA (United States)

Rachel Okabe is an author at Brigham and Women's Hospital specializing in medicine, cell biology, and hematology.

ORCID

Top concepts

Publications per year

2004–2019

19

Publications

19

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model

Gerlinde Wernig, Thomas Mercher, Rachel Okabe et al. · Blood · 2006 · 473 citations · Full text

Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia

Michael G. Kharas, Christopher J. Lengner, Fátima Al‐Shahrour et al. · Nature Medicine · 2010 · 393 citations · Full text

, , +3

Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells

Ann Mullally, Steven Lane, Brian Ball et al. · Cancer Cell · 2010 · 384 citations · Full text

, , +13

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera

Gerlinde Wernig, Michael G. Kharas, Rachel Okabe et al. · Cancer Cell · 2008 · 380 citations · Full text

, , +8

Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice

Michael G. Kharas, Rachel Okabe, Jared J. Ganis et al. · Blood · 2009 · 270 citations · Full text

Rows per page

1–5 of 19